Autophagy in brain tumors: a new target for therapeutic intervention

Niroop Kaza1, Latika Kohli, Kevin A Roth

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.

Insights

Autophagy, a cellular process, plays a key role in glioma development and presents a promising therapeutic target. Understanding this pathway could lead to new treatments for aggressive brain tumors.

Area of Science:

  • Oncology
  • Cell Biology
  • Neuroscience

Background:

  • Autophagy is a cellular recycling process with a newly recognized role in cancer development.
  • Gliomas are aggressive brain tumors with limited treatment options.
  • Apoptosis resistance is a common feature in cancers, driving the search for new therapeutic targets.

Purpose of the Study:

  • To review the current understanding of autophagy.
  • To explore the role of autophagy in glioma initiation and progression.
  • To evaluate autophagy as a potential therapeutic target for glioma treatment.

Main Methods:

  • Literature review of studies on autophagy and gliomas.
  • Analysis of the autophagic lysosomal pathway in cancer.
  • Synthesis of current research on therapeutic strategies targeting autophagy.

Main Results:

  • Autophagy is implicated in multiple stages of tumor development, including gliomas.
  • The autophagy lysosomal pathway is a viable target for novel cancer therapies.
  • Targeting autophagy may offer a new strategy to overcome treatment resistance in gliomas.

Conclusions:

  • Autophagy is a critical process in glioma pathogenesis.
  • The autophagy lysosomal pathway represents a promising therapeutic target for gliomas.
  • Further research into modulating autophagy could significantly improve glioma patient outcomes.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...